Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Compliance
Enforcement Officials Encourage Companies to Ask the Hard Questions
Recently at the CBI Pharmaceutical Compliance Congress a group of State, DOJ and US Attorneys thoroughly reviewed the life cycle…
US Attorney: Consider the Strength of Your Corporate Compliance Program
U.S. Attorney for the District of Massachusetts, Carmen Ortiz, emphasized the importance of compliance programs early on during…
US Attorney Discusses Factors in Determining Potency of Prosecution
At the recent CBI Pharmaceutical Compliance Congress, U.S. Attorney for the District of New Jersey, Paul Fishman, discussed…